稳心颗粒联合胺碘酮治疗房颤合并频发室性心律失常的临床效果被引量：5

下载PDF

导出

摘要目的分析房颤合并频发室性心律失常采用稳心颗粒联合胺碘酮治疗的临床效果。方法盲选收治的90例房颤合并频发室性心律失常患者,均分为两组,对照组45例采用胺碘酮药物治疗,观察组45例在胺碘酮治疗基础上结合采用稳心颗粒用药治疗,对比两种用药方法的治疗效果。结果观察组患者的症状治疗效果以及Holter疗效均无明显差异(P>0.05),但观察组患者的长间期发生情况明显少于对照组,差异有统计学意义(P<0.05)。结论房颤合并频发室性心律失常患者采用稳心颗粒联合胺碘酮用药治疗,可有效控制心律失常,应用安全可靠,值得应用推广到临床治疗中。

作者王又和

机构地区汉川市人民医院心血管内科

出处《中国处方药》 2015年第4期69-70,共2页 Journal of China Prescription Drug

关键词房颤合并频发室性心律失常稳心颗粒胺碘酮

分类号 R541.7 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献4

1董青.稳心颗粒联合胺碘酮治疗房颤合并频发室性心律失常的疗效观察[J].世界中西医结合杂志,2013,8(5):498-499. 被引量：14
2孟立立.稳心颗粒联合胺碘酮治疗房颤合并频发室性心律失常临床效果研究[J].中国社区医师（医学专业）,2014,16(13):81-81. 被引量：3
3陶赟臻,赵晓秋,柳江红,任素霞,周万先.宁心宝胶囊联合胺碘酮在不稳定型心绞痛伴室性心律失常中的临床应用[J].海南医学,2014,25(15):2266-2268. 被引量：12
4彭晓云.比索洛尔对高血压左室肥厚患者心室跨壁离散度及室性心律失常的影响[J].安徽医药,2014,18(6):1141-1143. 被引量：5

二级参考文献28

1陈新,黄宛.临床心电图学[M].6版.北京:人民卫生出版社,2010:551-558.
2Bardy GH, Lee KL, Mark DB, et al. Amiodaroneor and implantable cardioverler - defibrillator for congestive heart failure [ J ]. N Engl JMed ,2005,352 (3) :225 - 237.
3Day CP, McComb JM, Campbell RW. QT dispersion:an indication of arrhythomid risk in patients with long QT intervals[ J ]. Br Heart J, 1990,63 (6) :342 - 344.
4Yan GX, Antzelevitcb C. Cellular basis for the normal T wave and the electrocardiographic manilestations of the long-QTsyndrome [ J]. Circulation, 1998,98 ( 18 ) : 1928 - 1936.
5Castro Hevia J, Antzelevitcb C, Tomes Barzaga F, et al. Tpeak- Tend and Tpeak-Tend dispersion as risk factors for ventricular tachycardia/ventrieular fibrillation in patients with the Brugada syndrome[ J ]. J Am Coll Cardiol,2006,47 ( 9 ) : 1828 - 1834.
6Akar FG, Yah GX,Antzelevitch C, et al. Unique lopographical dis- tribution of M cells underlies reentrant mechanism of torsade de pointes in the long-QT syndrome[ J]. Circulation,2002,105 (10) : 1247 - 1253.
7Haarmark C, Hansen PR, Vedel-Larsen E, et al. The prognostic value of the Tpeak-Tend interval in patients undergoing primmy percutaneous coronary intervention for ST-segment elevation myo- cardial infarction [ J ]. J Electrocardiol, 2009,42 ( 6 ) : 555 - 560.
8Pittenger B, Gill EA, Holcslaw TL, et al. Relation of dose of carve- dilol to reduction in QT dispersion in patients with mild to moder- ate heart failure secondary to ischemic or to idiopathic dilated car- Aiomyopathy [ J ]. Am J Cardiol, 2004,94 ( 11 ) : 1459 - 1462.
9Zamaklar-Trifunovic D, Seferovic PM, Zivkovic M, etal. Influence of heart failure severity on heart rate variability[ J]. Srp Arh Celok Lek,2005,133(11/12) :484 -491.
10Sisakian H, Torgomyan A, Barkhudaryan A. The effect of Irimetazi-dine on left ventricular systolic function and physical tolerance in patients with ischaemic cardiomyopathy [J]. Acta Cardiol, 2007, 62 (5): 493-499.